NCT02521714View on ClinicalTrials.gov

Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Suspension

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

August 14, 2015

Primary Completion Date

September 23, 2015

Study Completion Date

September 23, 2015

Conditions

Healthy Volunteers

Interventions

DRUG

Lenalidomide

Trial Locations (1)

32117

Covance-Daytona Beach, Daytona Beach

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celgene

INDUSTRY